Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemed Corporation's diversified revenue streams from VITAS Healthcare and Roto-Rooter provide a strong competitive advantage and resilience against sector-specific risks. Recent VITAS acquisition and
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Astrana Health, Inc. (ASTH) or Chemed (CHE). But which of these two stocks offers valu
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks offers value investors a better bang fo
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the contin
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30
Chemtrade Logistics Income Fund (OTC:CGIFF) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Rohit Bhardwaj – Chief Financial Officer Scott Rook – President and Chief
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, a
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attrac
Chemed delivers first-quarter top-line growth across two of its segments, VITAS and Roto-Rooter.
Chemed Corporation (NYSE:CHE ) Q1 2025 Earnings Conference Call April 24, 2025 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and CEO Mike Witzeman -
Chemed (CHE) came out with quarterly earnings of $5.63 per share, beating the Zacks Consensus Estimate of $5.60 per share. This compares to earnings of $5.20 per share a year ago.

Chemed Reports First-Quarter 2025 Results

04:15pm, Wednesday, 23'rd Apr 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, t
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE